Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial

Rationale: Exogenous angiotensin II increases mean arterial pressure in patients with catecholamine-resistant vasodilatory shock (CRVS). We hypothesized that renin concentrations may identify patients most likely to benefit from such therapy. Objectives: To test the kinetic changes in renin concentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellomo, Rinaldo, Forni, Lui G., Busse, Laurence W., McCurdy, Michael T., Ham, Kealy R., Boldt, David W., Hästbacka, Johanna, Khanna, Ashish K., Albertson, Timothy E., Tumlin, James, Storey, Kristine, Handisides, Damian, Tidmarsh, George F., Chawla, Lakhmir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605187/
https://www.ncbi.nlm.nih.gov/pubmed/32609011
http://dx.doi.org/10.1164/rccm.201911-2172OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605187/
https://www.ncbi.nlm.nih.gov/pubmed/32609011
http://dx.doi.org/10.1164/rccm.201911-2172OC

Ejemplares similares